Donate
CAR T Therapy and Bispecific Antibodies Banner Desktop

CAR T Therapy & Bispecific Antibodies – What you need to know

About this event

Join us in-person in Sydney as we host experts and Haematologists presenting on the latest must-know information about CAR T-cell therapy and Bispecific antibodies.

This event is for Patients and Carers – Presented by Lymphoma Australia & ALLG.

Agenda

Time Activity Duration
12.30pm Registration and light lunch on arrival 30
1pm Welcome – Lymphoma Australia & ALLG 5
1.05pm CAR T Therapy & Bispecific Antibodies – Staying informed & making the choice

Clinicians x 2: CAR T Therapy – Dr Koon Lee (Westmead) / Bispecifics Antibodies – Dr Janlyn Falconer (Concord)

 60
2.05pm CAR T Treatments & Logistics – What you need to know

Karen Maddock, Westmead CAR T nurse

 30
2.35 pm Access to Treatments & Understanding Clinical Trials

Professor Judith Trotman, Concord Hospital / ALLG

 15
2.50pm Panel Q&A Session 30
3.15pm Afternoon Tea 30
3.45 pm Close

For more information contact our nurses on the Lymphoma Support Line on 1800 953 081.

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Tuesday 13th of May 2025
Time: 12:30pm AEST - 3:45pm AEST
Location: Essex Room, Shangri La Hotel, Sydney
176 Cumberland Street, Sydney
Register to attend

Support and information

Patient Online Forum

Find Out More

Order Our Resources

Find Out More

Fundraise for us

Get started

Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.